SpeechPathology.com Phone: 800-242-5183


eLuma Online Therapy - Love What You Do - May 2023

VitalStim: Rationale for Treating Patients with Dysphagia

Michael Crary, Ph.D

March 17, 2008

Share:

Question

My father has recently suffered a stroke and is currently having Vital Stim therapy used on him. I'm moving him to rehab and have been told he MUST continue with Vital Stim. Other speech therapists have indicated that traditional therapies are "the way t

Answer

First, I dislike the emphasis on 'must'. But, to understand my views, a little background on VitalStim is important. VitalStim is a commericial electrical stimulation system that provides a specific pattern of electrical stimulation to muscle groups from electrodes placed on the skin over those muscle groups. While clinical research in swallowing applications is only now emerging, 'estim' has a long history of effective use in physical therapy and sports medicine. The basic concept is that estim facilitates improved muscle contraction in the muscles being stimulated. That said, the application of VitalStim as a form of estim has a valid rationale. Furthermore, this same body of research suggests that estim works most effectively when applied in conjunction with a well developed exercise-based intervention program. The reason that I object to the term 'must' is that our own research suggests a wide degree of clinical application of the VitalStim units. Some clinicians use estim in isolation, others use it with various, but all different, swallowing maneuvers and/or compensations. Some clinicians report using estim with a sensory approach to swallowing therapy. Given this variability in application it makes absolutely no sense to mandate that any patient 'must' receive VitalStim therapy without knowing what the underlying 'therapy' will be. Then and only then can any clinician determine if the application of any estim will support the basic therapy approach.

Our laboratory and others have been evaluating estim effects on swallowing. In our laboratory we have developed a specific, exercise-based therapy approach which uses adjunctive estim. We have termed this approach the 'McNeill Dysphagia Therapy Program" or MDTP. We have tested this approach on stroke patients and patients with dysphagia following treatment for head/neck cancer. Even in chronic cases we have been able to obtain positive results. Bottom line...the application of the VitalStim unit for electrical stimulation combined with a systematic therapy program can produce effective results even in severe, chronic dysphagia.

Given this perspective, I would suggest that you ask the treating clinicians to describe the underlying problems in your father's swallow, how they propose to treat those problems, and how the application of any estim will potentially benefit your father's swallowing ability. This clinical modality has much promise, but as a profession, we have much to learn toward the successful application of estim.

Michael Crary is a Professor of Speech-Language Pathology at the University of Florida Health Science Center. He directs the Swallowing Research Laboratory housed within the medical center. More information on the activities of the Swallowing Research Laboratory may be found at their website srl.phhp.ufl.edu


michael crary

Michael Crary, Ph.D


Related Courses

Thickened Liquids in Clinical Practice: The Plot “Thickens”
Presented by Angela Mansolillo, MA, CCC-SLP, BCS-S
Video

Presenter

Angela Mansolillo, MA, CCC-SLP, BCS-S
Course: #10497Level: Intermediate1 Hour
  'I work in the acute care setting and found this course extremely helpful'   Read Reviews
Clinicians who utilize thickened liquids in their clinical practice are aware of their benefits, but what about the risks and contraindications? Advantages and disadvantages of thickened liquids are reviewed in this course with a focus on clinical outcomes, including impacts on medication administration, lung health, and hydration. Product types are evaluated to facilitate appropriate choices for individual clients.

Dysphagia in Neurodegenerative Disease
Presented by Debra M. Suiter, PhD, CCC-SLP, BCS-S
Video

Presenter

Debra M. Suiter, PhD, CCC-SLP, BCS-S
Course: #9732Level: Intermediate1 Hour
  'This course taught me a great deal about ALS and reinforced knowledge of dysphagia in Parkinson’s, esp tx'   Read Reviews
Dysphagia is common in individuals with amyotrophic lateral sclerosis (ALS) and Parkinson’s disease. This course discusses the underlying pathophysiology and appropriate treatment programs for each disease, as well as use of alternate methods of nutrition/hydration.

20Q: In the Thick of It - The International Dysphagia Diet Standardization Initiative (IDDSI)
Presented by Jennifer Raminick, MA, CCC-SLP, BCS-S, Danielle Ward, MA, CCC-SLP
Text

Presenters

Jennifer Raminick, MA, CCC-SLP, BCS-SDanielle Ward, MA, CCC-SLP
Course: #10756Level: Intermediate1 Hour
  'Specifically how to implement at a facility'   Read Reviews
The importance of using IDSSI to provide standardized language when speaking about texture modification is discussed in this course. Comparisons of IDDSI and the National Dysphagia Diet (NDD), as well as IDDSI standards for pediatric vs. adult patients are presented. Additionally, potential barriers, solutions, and frequently asked questions related to implementation of IDDSI are described.

Back to Basics: Swallow Screening: How, when, and who
Presented by Angela Mansolillo, MA, CCC-SLP, BCS-S
Video

Presenter

Angela Mansolillo, MA, CCC-SLP, BCS-S
Course: #8969Level: Introductory1 Hour
  'A great reference'   Read Reviews
Screening of swallow function is a well-regarded tool to identify individuals who are potentially at risk of dysphagia and in need of full swallow assessment, but the options are many and varied. This "back to basics" course will teach participants to make informed, evidence-based choices regarding appropriate screening tools specific to their particular patient populations and settings.

ALS: Medications and Oral Care
Presented by Denise Dougherty, MA, SLP
Video

Presenter

Denise Dougherty, MA, SLP
Course: #8717Level: Intermediate1 Hour
  'This course provided pertinent and applicable information regarding medications and oral care related to ALS'   Read Reviews
This is Part 1 of a three-part series on amyotrophic lateral sclerosis (ALS). This course will identify medication and complementary alternative medicine that may be used by patients to treat ALS. The importance of saliva management and mouth care as a critical component of their daily care will be discussed, along with strategies. (Part 2: Course #8719, Part 3: #8720)

Our site uses cookies to improve your experience. By using our site, you agree to our Privacy Policy.